- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Lipid Absorption and Metabolism in Hong Kong
Total 792 results
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesMalaysia, Australia, Taiwan, Thailand, Hong Kong, Singapore, Philippines
-
AmgenCompletedHomozygous Familial HypercholesterolemiaNew Zealand, South Africa, France, United States, Spain, Belgium, Czechia, Italy, Netherlands, Hong Kong, Canada, Lebanon
-
Eli Lilly and CompanyCompleted
-
AstraZenecaCompletedHypercholesterolemiaChina, Taiwan, Malaysia, Hong Kong, Korea, Republic of, Thailand
-
TakedaTerminatedDiabetes Mellitus, Type 2China, Hong Kong
-
AstraZenecaCompleted
-
Baxter Healthcare CorporationCompletedDiabetes | ESRD | CAPD | APDTaiwan, Korea, Republic of, Singapore, Hong Kong, Russian Federation
-
SanofiCompletedType 2 Diabetes MellitusArgentina, Colombia, Egypt, Hong Kong, India, Indonesia, Lebanon, Malaysia, Peru, Philippines, Saudi Arabia, South Africa, Thailand, Turkey
-
AmgenCompletedHyperlipidemiaCanada, France, Netherlands, United Kingdom, New Zealand, South Africa, Spain, United States, Australia, Germany, Sweden, Hong Kong, Switzerland, Norway
-
PharmaNest, IncIcahn School of Medicine at Mount Sinai; Chinese University of Hong Kong; Imperial... and other collaboratorsNot yet recruitingMetabolic Dysfunction-associated Steatotic Liver DiseaseUnited States, Hong Kong, United Kingdom, Spain
-
BayerCompletedDiabetes MellitusRussian Federation, India, Korea, Republic of, Indonesia, Malaysia, Philippines, Singapore, Thailand, China, Hong Kong, Pakistan, Vietnam, Algeria, Moldova, Republic of, Bosnia and Herzegovina, Cambodia
-
TakedaCompletedType 2 Diabetes Mellitus | Essential HypertensionTaiwan, Thailand, China
-
International Diabetes Institute, AustraliaGlaxoSmithKlineCompletedType 2 Diabetes MellitusChina, Indonesia, Korea, Republic of, Malaysia, Philippines, Singapore, Taiwan, Thailand, Vietnam
-
AmgenCompletedSevere Familial HypercholesterolemiaItaly, Czechia, United States, Israel, New Zealand, South Africa, France, Spain, Australia, Belgium, Canada, Netherlands, Hong Kong, Brazil, United Kingdom, Greece, Japan, Lebanon
-
DePuy InternationalTerminatedOsteoarthritis | Rheumatoid Arthritis | Avascular Necrosis | Post-traumatic Arthritis | Congenital Hip Dysplasia | Slipped Capital Femoral Epiphysis | Collagen Disorders | Traumatic Femoral Fractures | Nonunion of Femoral FracturesChina, Hong Kong, Italy, Korea, Republic of, New Zealand
-
AmgenCompletedHyperlipidemiaUnited States, Denmark, Belgium, Germany, Hong Kong, Netherlands, France, Australia, Canada, South Africa, United Kingdom, Spain, Poland, Switzerland
-
SanofiCompletedType 2 Diabetes MellitusChina, Hong Kong, Malaysia, Thailand
-
AstraZenecaCompletedHypercholesterolemiaKorea, Republic of, Vietnam, Malaysia, Taiwan, Philippines, China, Indonesia, Thailand
-
Hoffmann-La RocheCompletedPost Menopausal OsteoporosisPhilippines, Taiwan, Thailand, Hong Kong, Indonesia
-
AO Clinical Investigation and Publishing DocumentationCompletedPoor Bone Quality | Treatment Complications | Proximal Humeral FracturesSwitzerland, China, Germany, Austria
-
TakedaTerminatedHypercholesterolemiaUnited States
-
University of California, IrvineUniversity of WashingtonCompleted
-
BIOTRONIK Asia Pacific Pte LtdCompletedMyocardial Ischemia | Coronary Artery Disease | Diabetes Mellitus Type 1 or 2China, India, Malaysia, Vietnam, Sri Lanka
-
Merck Sharp & Dohme LLCActive, not recruitingHypercholesterolemia | Familial HypercholesterolemiaUnited States, Australia, Brazil, Canada, Chile, Colombia, Czechia, Finland, Hong Kong, Hungary, Israel, Netherlands, New Zealand, Norway, Singapore, Spain, Taiwan
-
AstraZenecaCompleted
-
Boehringer IngelheimCompletedCombination of Telmisartan and Simvastatin in the Treatment of Hypertension and HypercholesterolemiaHypertension | DyslipidemiasTaiwan, Netherlands, Czech Republic, France, Germany, Hong Kong, Korea, Republic of, Russian Federation, Slovakia, South Africa, Sweden, Ukraine
-
Novartis PharmaceuticalsActive, not recruitingPrimary Hypercholesterolemia or Mixed DyslipidemiaChina
-
University of California, San FranciscoOregon Health and Science University; Society of Family Planning; FPA Women's...CompletedAbortionUnited States
-
PfizerCompletedHyperlipidemiaKorea, Republic of, United States, Australia, Germany, Poland, Canada, Italy, Hong Kong, Czech Republic
-
PfizerCompletedDyslipidemia | HypercholesterolemiaUnited States, Canada
-
Novo Nordisk A/SCompletedComparison of Human Insulin Produced by the Current Process and the NN729 Process in Type 1 DiabetesDiabetes | Diabetes Mellitus, Type 1Malaysia, Australia, Hong Kong, Philippines
-
TakedaCompletedDyslipidemiaUnited States
-
University of MichiganMahidol University; Fogarty International Center of the National Institute...CompletedType 2 Diabetes MellitusThailand
-
TakedaCompletedDiabetes Mellitus, Type 2Hong Kong, China, Taiwan
-
ShionogiIntegriumCompletedCombined HyperlipidemiaUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesMalaysia, South Africa, Hong Kong, Taiwan, Philippines
-
TakedaCompletedHyperlipidemiasUnited States, Canada
-
AmgenCompletedHyperlipidemiaUnited States, Denmark, France, Italy, Czechia, Taiwan, Switzerland, Korea, Republic of, Germany, Hong Kong, Netherlands, Australia, Belgium, Canada, Hungary, South Africa, Russian Federation, Spain, United Kingdom, Sweden, Mexico
-
Kowa Research Institute, Inc.Eli Lilly and Company; Kowa Pharmaceuticals America, Inc.CompletedDyslipidemiaUnited States
-
MemorialCare Health SystemDexCom, Inc.RecruitingHyperinsulinism | Hypoglycemia NeonatalUnited States
-
Bristol-Myers SquibbCompletedDyslipidemiaUnited States, Canada
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedHypertension | HyperlipidemiaBrazil, Turkey, Taiwan, Argentina, India, Philippines, Singapore, Thailand, Australia, Chile, South Africa, Jordan, Korea, Republic of, Lebanon, United Arab Emirates, Malaysia, Peru, Israel, Indonesia, Guatemala, Hong Kong, Kuwait, ... and more
-
Eli Lilly and CompanyCompletedOsteoporosisIndia, Mexico, Hong Kong, Taiwan, Korea, Republic of, Thailand, Malaysia, Pakistan, Singapore
-
Kastle Therapeutics, LLCCompletedHypercholesterolemia | Heterozygous FamilialUnited States, Italy, Poland, Ukraine, United Kingdom, Germany, Hong Kong, Taiwan, Spain, Argentina, Belgium, Israel, Malaysia, South Africa, Turkey, Netherlands, Korea, Republic of, Canada, New Zealand, Russian Federation, Brazil, Austral... and more
-
Pfizer's Upjohn has merged with Mylan to form Viatris...Completed
-
Arrowhead PharmaceuticalsActive, not recruitingDyslipidemiasUnited States, Australia, Canada, Poland, Netherlands, New Zealand, Hungary
-
Acasti Pharma Inc.CompletedHypertriglyceridemiaUnited States, Mexico, Canada
-
JW PharmaceuticalCompletedHyperuricemia | GoutKorea, Republic of
-
Akcea TherapeuticsIonis Pharmaceuticals, Inc.CompletedCardiovascular Diseases | HypertriglyceridemiaUnited States, Canada
-
Esperion Therapeutics, Inc.Medpace, Inc.CompletedHypercholesterolemiaUnited States